Loading...
1.0 CIMCITY COMMISSION INFORMATION MEMORANDUM ADMINISTRATIVE BRIEF FROM MARTHA TASKER September 26, 2022 UTILITIES DEPARTMENT Wastewater Sampling Program The City of Salina is participating in a nationwide initiative to monitor infectious diseases by sampling and analyzing the genetic material in wastewater from our treatment plant. The program is part of the Wastewater Sewer Coronavirus Alert Network (WastewaterSCAN) that is being led by researchers at Stanford University and Emory University. The City is working with Verily Life Sciences for the sampling program for this project. Data will be available on a public website ( http://publichealth.verily.com/ ). Wastewater plants in participating communities sample three times a week and are provided with materials to ship the containers to Verily's lab for analysis including detection of viral genetic material with PCR -based technology. The materials and shipping are free to the communities, and stipends are available to defray some labor costs for sampling. WastewaterSCAN's national expansion was made possible thanks to support from the Sergey Brin Family Foundation and Bloomberg Philanthropies. WastewaterSCAN aims to demonstrate the value of a national sentinel system using wastewater to inform public health measures and to support the establishment of publicly funded, durable public health infrastructure to prepare for future pandemics. "Because it's population -based and unbiased by access to clinical testing, wastewater helps us understand infectious disease trends in a community. We've seen how valuable this can be as individual testing practices for SARS-CoV-2 have changed," said Alexandria Boehm, professor of civil and environmental engineering at Stanford. "Genetic material of the pathogens we monitor has been documented in excretions from infected people that end up in the wastewater treatment system." The scientists at Stanford and Emory are working with Verily Life Sciences, which collaborates to optimize methods for high throughput, test samples, and produce data in its lab, and with local wastewater and public health officials to produce actionable data about COVID-19 and other pathogens. The analytical approach does not measure infectious viruses in wastewater, but instead detects the presence of genetic markers of the virus. Presently there are 52 wastewater plants in this sampling program. Those plants are in 17 states and include almost 20 million persons served by those plants. In Kansas, there are 2 plants — Salina and Lawrence. WASHINGTON • OPIGON IDAHO 4; NEVADA UTAH NORTH MONTANA DAKOTA i 9�'a � N VIEORNIA MINNESOTA SOUTH WISCONSIN MAINE' DAKOTA 'VT MICHIGAN (MING NEW YORK NN IOWA -SEVMA NEBRASKA RI ESL. ILLINOIS OHIO OEN� VAlled States • INDIANA AID COLORADO KANIPf MISSOURI • WEST { VIRGINIA KENTUCKY VIRGINIA OKLAHOMA TENNESSEE ma-TRTN ARKANSAS . a CAROLINA IEKICO • MISSISSIP0 SOUTH CAROLI ALABA� TEXAS GEORGIA Mexico Bubble size represents sewershed population, ranging from 3,776 - 4,000,000 Sampling Sites Map The testing results do not determine exact numbers of persons infected, but do show if the presence of covid is increasing or decreasing in the community. SAPSSCOV 2 MONKEYPDX Salina, KS Sap 14, 2022 VN9/VFKm CopeV4 — AN SARS-0oV2 1820X1 Is n—) — Omicron (BA.4&BA-5) 14],3]4 MaIrror, SHVr470det — Omicron IRA.2 BA -4 A BA 5) MNolion <LPP42af • NOEeS fepesem smooMe05amPle raWes on ccAxtirn Cates. wMcc a'e m[ alwap m rzg W� mxsals _ rnmr es na,a ae.a smounea p maao are cava I cM aSpApO copies ce�anm 3W toO t 50.000 a PMMoV Normalized I All time • Graph Table Recent Salina Test Results SAaa M2 MONKEYPDX Lawrence. NS Sap 12.2022 Vlma r Vanant ctyiaerq All SABSCOV-2 226,797 (c Gene) Omicron(BA.48 BA.5) 238.766 FlNauon:5NY5u?M, Omicron (BA2, BA 48 BA.S) WaLon SLPPA24i • NWea rep.—:zmwlMO mmple,alupson wlipCtb+Calcw�rtir are rwt always at regaY[ �m..pais — nem ones the even smo ,,o Oown oae rew dale 1CO a PMMOV Normalized All time - rBnpA l Table 7K"Copiesp gram SW Wa 2W.Wc n••�: .age <... Auq s� Recent Lawrence Test Results A significant advantage of this type of testing is that it is monitoring the presence of this genetic material with only a few days of lag time and is a more complete cross-section of the population of these communities. The results are not dependent on the reporting of individual test results and do include persons that may not have any apparent symptoms. The program would like to grow to at least 300 communities being monitored.